Account
Inquiry
XCE tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research applications. This pharmaceutical grade compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The XCE tirzepatide formulation shows particular affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique dual agonist profile has been shown to produce enhanced reductions in hyperglycemia in research settings. The compound mimics the actions of natural GIP at the GIP receptor while providing the established benefits of GLP-1 receptor activation.
Our XCE tirzepatide is supplied as a white powder with purity exceeding 99%, making it ideal for research applications. The product undergoes rigorous quality control testing to ensure batch-to-batch consistency and meets all pharmaceutical grade specifications.
For research use only. Not for human consumption. This product is intended solely for laboratory research purposes by qualified professionals.
